198 PRISM cell lines were pooled and profiled by scRNAseq with the 10X Genomics Chromium system. This work compiled the landscape of heterogeneity across cancer cell lines and identified recurrent programs of cellular heterogeneity shared between tumors and certain cell lines.
Menu
PRISM will be accepting submissions for our next screen May 27 – June 13!
DMSO-soluble small molecules (single agent and combination format) and single agent antibodies, ADCs, and growth-inhibiting cytokines will be accepted for our 930 cancer cell line screen.
